Eli Lilly Sues Actavis To Block Generic ADHD Drug
By Ben James · August 10, 2007, 12:00 AM EDT
Eli Lilly & Co. has filed a lawsuit against a U.S. subsidiary of Iceland-based Actavis, looking to stave off generic competition in the $509 million annual U.S. market for the attention-deficit...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login